CD55 Antikörper (PE)
Kurzübersicht für CD55 Antikörper (PE) (ABIN7566577)
Target
Alle CD55 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
Klon
-
-
Verwendungszweck
- PE Anti-Human CD55 Antibody[HI55a]
-
Isotyp
- IgG2a, kappa
-
-
-
-
Applikationshinweise
-
Each lot of this antibody is quality control tested by flow cytometric analysis. Applications vary, the appropriate dilutions must be determined for individual use.
FCM: 5 µL/test -
Kommentare
-
Matching Isotype Control: (ABIN7469778)
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Buffer
- Phosphate buffered solution, pH 7.2, containing 0.09 % stabilizer and 1 % protein protectant.
-
Lagerung
- 4 °C
-
Informationen zur Lagerung
- This product can be stored at 2-8°C for 12 months. Please protected from prolonged exposure to light and do not freeze.
-
Haltbarkeit
- 12 months
-
-
- CD55 (Complement Decay-Accelerating Factor (CD55))
-
Andere Bezeichnung
- CD55
-
Hintergrund
- Complementdecay-acceleratingfactor,CD55,CR,DAF,CD55 is a 60-70 kD glycosylphosphatidylinositol (GPI)-anchored single chain glycoprotein also known as decay-accelerating factor (DAF). It is expressed on hematopoietic cells including erythrocytes and many non-hematopoietic cells. CD55 accelerates the dissociation of the components of the C3-convertases (namely C2a from C4b in the C4bC2a complex, a C3-convertase of the classical pathway, and factor Bb from the C3bBb complex, a C3-convertase of the alternative pathway) to protect cells from inappropriate damage caused by autologous complement. CD55 has been reported to reduce the efficiency of NK cell lysis and induce signal transduction in T cells. CD55 has also been shown to interact with CD97 and bind to Coxsackie and Echovirus.
-
Gen-ID
- 1604
-
UniProt
- P13591
-
Pathways
- Komplementsystem, Regulation of Leukocyte Mediated Immunity
Target
-